Explanipedia

Multiphase preclinical assessment of a novel device to locate unintentionally retained surgical sharps: a proof-of-concept study Open

Hae Sung Kang, Jad Khoraki, Jessie Gie, Dielle Duval, Susan Haynes , et al. · 2023

Background Retained surgical sharps (RSS) is a “never event” that is preventable but may still occur despite of correct count and negative X-ray. This study assesses the feasibility of a novel device (“Melzi Sharps Finder®” or MSF) in effe…

V06-07 ROBOTIC ASSISTED BUCCAL MUCOSA GRAFT POSTERIOR URETHROPLASTY Open

Min Jun, Michael Siev, Lee C. Zhao · 2020

You have accessJournal of UrologyLower-Tract Reconstruction I: Sling/ Sphincter/ Penile & Urethral Reconstruction (V06)1 Apr 2020V06-07 ROBOTIC ASSISTED BUCCAL MUCOSA GRAFT POSTERIOR URETHROPLASTY Min Suk Jun*, Michael Siev, and Lee Zhao M…

Editorial Comment: Impact of preoperative urodynamics on women undergoing pelvic organ prolapse surgery Open

Dianne Glass, Lin Fc, AA Khan, Michelle Van Kuiken, Alice Drain , et al. · 2020

Prognostic Value of Histologic Subtype and Treatment Modality for T1a Kidney Cancers Open

Michael Siev, Audrey Renson, Hung‐Jui Tan, Tracy L. Rose, Stella K. Kang , et al. · 2020

Introduction: To evaluate overall survival (OS) of T1a kidney cancers stratified by histologic subtype and curative treatment including partial nephrectomy (PN), percutaneous ablation (PA), and radical nephrectomy (RN). Materials and Metho…

MP46-15 DEMOGRAPHIC, HEALTH STATUS, AND HEALTHCARE UTILIZATION CHARACTERISTICS OF MEN UNDERGOING VASECTOMY IN THE UNITED STATES Open

Michael Siev, Michael Schulster, Wen Liu, Jesse Persily, Bobby B. Najari · 2019

You have accessJournal of UrologyInfertility: Epidemiology & Evaluation II (MP46)1 Apr 2019MP46-15 DEMOGRAPHIC, HEALTH STATUS, AND HEALTHCARE UTILIZATION CHARACTERISTICS OF MEN UNDERGOING VASECTOMY IN THE UNITED STATES Michael Siev*, Micha…

PD51-12 PROGNOSTIC VALUE OF HISTOLOGIC SUBTYPE AND TREATMENT MODALITY FOR T1A KIDNEY CANCERS Open

Michael Siev, Audrey Renson, Stella K. Kang, William C. Huang, Marc A. Bjurlin · 2019

You have accessJournal of UrologyKidney Cancer: Ablative Therapy (PD51)1 Apr 2019PD51-12 PROGNOSTIC VALUE OF HISTOLOGIC SUBTYPE AND TREATMENT MODALITY FOR T1A KIDNEY CANCERS Michael Siev*, Audrey Renson, Stella Kang, William Huang, and Mar…

Stenting for malignant ureteral obstruction: Tandem, metal or metal‐mesh stents Open

Sammy Elsamra, David Leavitt, Hector Motato, Justin I. Friedlander, Michael Siev , et al. · 2015

Extrinsic malignant compression of the ureter is not uncommon, often refractory to decompression with conventional polymeric ureteral stents, and frequently associated with limited survival. Alternative options for decompression include ta…

The impact of obesity on prostate cancer recurrence observed after exclusion of diabetics Open

Ilir Agalliu, Steve K. Williams, Brandon Adler, Lagu Androga, Michael Siev , et al. · 2015

Michael Siev YOU? Author Swipe